MK-5204

• UNSPSC Description:

  MK-5204 is an orally active β-1,3-glucan synthesis inhibitor.

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/mk-5204.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@@]12[C@@](CC3)([H])[C@@](C[C@](N4C(C(N)=O)=NC=N4)([H])[C@@H]1OC[C@](C)(N)C(C)(C)C)(COC2)C([C@@]3([H])[C@]5(CC[C@]6(C)[C@H](C)C(C)C)C)=CC[C@]5([C@@H]6C(O)=O)C

• Molecular Weight:

  695.97

• References & Citations:

  [1]Apgar JM, et al. MK-5204: An orally active β-1,3-glucan synthesis inhibitor. Bioorg Med Chem Lett. 2020 Sep 1;30(17):127357.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1207751-75-4